Sales of Assets in Vietnam

RNS Number : 7369J
Aseana Properties Limited
25 August 2021
 

25 August 2021

 

Aseana Properties Limited

("Aseana" or the "Company")

 

Sales of our assets in Vietnam

 

 

Aseana Properties Limited (LSE: ASPL), a property developer in Malaysia and Vietnam which is listed on the Main Market of the London Stock Exchange, announces tha t following a competitive bidding process it has signed a binding agreement to sell its interests in both the City International Hospital and the adjacent International Healthcare Park in Ho Chi Minh City, Vietnam to its joint venture partner, the Hoa Lam Corporation . Following these sales the Company will have no assets in Vietnam and will concentrate on realising its remaining four assets in Malaysia.

 

The gross sales price of the transaction is approximately USD $95 million and under the terms of the agreement, the buyer will settle all bank debts owed on these two assets. Completion of the transaction is expected to take place over the next few months subject to approvals from regulatory authorities as required. A further announcement will be made upon completion and the receipt of net proceeds by the Company.

 

The Directors of the Company express their thanks to the Hoa Lam Corporation for a long and co-operative joint venture partnership. Nicholas Paris, Chairman of Aseana commented that "we have been very pleased to be part of the team that built such an excellent hospital facility in the City of Ho Chi Minh and that we thank our joint venture partner and our hospital staff for making that possible".

 

   

For further information:

 

Aseana Properties Limited

Tel: 020 3325 7050

Nick Paris (Chairman)

nickparis@btinternet.com 

 

Liberum Capital

Tel: 020 3100 2000

Darren Vickers / Owen Matthews

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DISDKPBBFBKKBFB
UK 100

Latest directors dealings